Riskpilot← Back to searchSign inGet full accessTERAPIA AS
ASActiveOrg 998099048Emil Korsmos vei 21, 0678 OsloRetail sale of cosmetic and toilet articles · NACE 4775Est. 20120 employees
Revenue 2025
NOK 118K
+13% vs 2024
EBITDA margin
27.3%
+92% vs 2024
Equity ratio
80.7%
Financial strength
Net profit 2025
NOK 25K
+52% vs 2024
| Revenue | NOK 118K | +13% |
| EBITDA | NOK 32K | +92% |
| Net profit | NOK 25K | +52% |
| Total assets | NOK 173K | +23% |
| Equity | NOK 140K | +22% |
| Employees | 0 | — |
Legal name
TERAPIA AS
Org number
998099048
Legal form
Aksjeselskap
NACE code
4775 · Retail sale of cosmetic and toilet articles
Founded
14. mars 2012
Share capital
NOK 30 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Jan engebret bråthen
Company purpose
Import og salg av helserelaterte produkter, samt utøvelse av alternativ medisin.
Address
Emil Korsmos vei 21, 0678 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 122 | 137 | 153 | 142 | 164 | 90 | 99 | 141 | 134 | 136 | 130 | 125 | 104 | 118 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 48 | 56 | 53 | 27 | 36 | 20 | 23 | 38 | 21 | 19 | 34 | 33 | 17 | 32 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 48 | 56 | 53 | 27 | 36 | 20 | 23 | 38 | 21 | 19 | 34 | 33 | 17 | 32 |
| Net financials | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 2 | 4 | 0 |
| Profit before tax | 48 | 56 | 53 | 28 | 37 | 21 | 23 | 38 | 21 | 19 | 34 | 35 | 21 | 32 |
| Tax | −0 | 13 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | 8 | 5 | 7 |
| Net profit | 48 | 42 | 53 | 28 | 37 | 21 | 23 | 38 | 21 | 19 | 34 | 28 | 16 | 25 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 306 | 304 | 346 | 289 | 303 | 305 | 291 | 307 | 320 | 315 | 330 | 332 | 141 | 173 |
| Equity | 262 | 263 | 331 | 287 | 294 | 268 | 268 | 269 | 269 | 269 | 269 | 269 | 115 | 140 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 44 | 42 | 14 | 2 | 9 | 37 | 22 | 38 | 52 | 46 | 62 | 63 | 26 | 33 |
| Total debt | 44 | 42 | 14 | 2 | 9 | 37 | 22 | 38 | 52 | 46 | 62 | 63 | 26 | 33 |
EBITDA margin
27.3%
This company
15.8%
Market median
+73% vs market
20122025
Equity ratio
80.7%
This company
38.2%
Market median
+111% vs market
20122025
Return on equity
17.9%
This company
18.4%
Market median
+3% vs market
20122025
Net profit margin
21.3%
This company
8.1%
Market median
+163% vs market
20122025
Asset turnover
0.68×
This company
1.12×
Market median
-39% vs market
20122025
Debt / equity
0.24×
This company
0.62×
Market median
+61% vs market
20122025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-03-06 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
DS Chief Executive Officer | Chief Executive Officer | 2012 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 10.0% | 10.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of TERAPIA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Daniel Stephanek | Chief Executive Officer | 0 companies |